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Abstract The first step in intestinal iron absorption is mediated
by the H+-coupled Fe2+ transporter called divalent cation
transporter 1/divalent metal ion transporter 1 (DCT1/DMT1)
(also known as natural resistance-associated macrophage
protein 2). DCT1/DMT1 mRNA levels in the duodenum strongly
increase in response to iron depletion. To study the mechanism of
iron-dependent DCT1/DMT1 mRNA regulation, we investigated
the endogenous expression of DCT1/DMT1 mRNA in various
cell types. We found that only the iron responsive element (IRE)-
containing form, which corresponds to one of two splice forms of
DCT1/DMT1, is responsive to iron treatment and this respon-
siveness was cell type specific. We also examined the interaction
of the putative 3P-UTR IRE with iron responsive binding proteins
(IRP1 and IRP2), and found that IRP1 binds to the DCT1/
DMT1-IRE with higher affinity compared to IRP2. This
differential binding of IRP1 and IRP2 was also reported for
the IREs of transferrin receptors, erythroid 5-aminolevulinate
synthase and mitochondrial aconitase. We propose that regula-
tion of DCT1/DMT1 mRNA by iron involves post-transcrip-
tional regulation through the binding of IRP1 to the transporter’s
IRE, as well as other as yet unknown factors. ß 2001 Pub-
lished by Elsevier Science B.V. on behalf of the Federation of
European Biochemical Societies.
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1. Introduction
Iron is an essential nutrient in all living cells, yet it is toxic
when present in excess due to the generation of reactive oxy-
gen species [1,2]. Human iron metabolism is dependent on
e⁄cient cycling of iron from senescent to newly formed red
cells [3], and less than 0.05% of the total body iron is acquired
or lost each day, demonstrating the e¡ectiveness with which
iron is conserved. Therefore, iron levels in the body are tightly
controlled via regulation of intestinal absorption, circulating
erythrocytes, and storage in bone marrow, liver and spleen.
Recently, we identi¢ed divalent cation transporter 1/diva-
lent metal ion transporter 1 (DCT1/DMT1) as the major in-
testinal iron absorptive mechanism [4,5]. It is a widely ex-
pressed H-coupled divalent metal ion transporter that
accepts a variety of divalent metal ions [4]. It is strongly ex-
pressed in the duodenum where it mediates apical intestinal
iron uptake [4,6]. In rat duodenum, DCT1/DMT1 mRNA is
expressed primarily in the lower segments of the villi but not
at the villus tips or in the deep crypt. Its mRNA levels in-
creased 50^100-fold in rats kept on an iron-de¢cient diet for
3 weeks [4], indicating that this metal ion transporter plays a
crucial role in body iron homeostasis. Crypt cells, which take
up iron from the blood via the transferrin receptor (TfR), are
known to be the body iron sensors/responders. The current
concept is that, in response to increased body iron demand,
crypt cells may be ‘programmed’ to upregulate this transpor-
ter’s expression as they mature to become villus cells [24^26].
As part of this regulatory mechanism, cellular accumulation
of iron may lead to dissociation of iron regulatory protein
(IRP) from the DCT1/DMT1-IRE (iron responsive element),
resulting in degradation of its mRNA to cease intestinal iron
absorption.
Two spliced products were identi¢ed for DCT1/DMT1 in
several species [4,5,7]. One transcript contains a sequence that
resembles an IRE within its 3P-UTR [4], whereas the alterna-
tively spliced counterpart lacks this sequence and encodes a
protein that is seven amino acids longer at the C-terminus [8].
The IRE-like sequence of the rat duodenal DCT1/DMT1
mRNA is predicted to fold into a stem^loop structure which
resembles the IRE present in tandem in the 3P-UTR of the
TfR mRNA, and as a single copy in the 5P-UTR of ferritin
mRNAs [4]. Studies of TfR revealed that interaction of the
TfR-IREs with IRP1 and IRP2 protects the transcript against
endonucleolytic cleavage [9,10]. The binding of IRPs to the
IRE in the 5P-UTR of ferritin mRNA leads to the suppression
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of translational initiation. In addition to both ferritin H- and
L-chain mRNAs, functional IREs have been found in the 5P-
UTR of other transcripts, including the mRNA of erythroid
5-aminolevulinate synthase (eALAS), mitochondrial aconitase
(m-aconitase), subunit b of Drosophila melanogaster succinate
dehydrogenase, and, as revealed recently, the basolateral iron
transporter IREG1/Ferroportin1/MTP1 [11^19].
The previously characterized IREs share important se-
quence and structural similarities, or consensus elements,
characterized by a hexanucleotide loop (CAGUGN), and a
single unpaired or bulged C that is separated from the loop
by ¢ve complementary base pairs. Mutational studies [20^23]
revealed that the addition or subtraction of base pairs from
this region or the disruption of base-pairing through mis-
matches greatly diminished the ability of IRP1 and IRP2 to
bind to the RNA element. The initial interpretation was that
the IRE hairpin loop contributes more to IRP1 binding, and
the internal loop/bulge region contributes more to IRP2 bind-
ing [21,35], although further studies are needed to address this
hypothesis.
Hereditary hemochromatosis (HH) is a common autosomal
recessive disorder. Its major causes are missense mutations
(mostly C282Y) in the gene encoding HFE, a major histocom-
patibility complex class I-like protein. In patients with HH,
the crypt iron sensor/responder is thought to be disturbed, as
suggested by ¢ndings in HFE knockout mice, in which DCT1/
DMT1 is upregulated, despite high serum and liver iron levels
[27]. Consistent with this, DCT1/DMT1 mRNA expression in
duodenal mucosa is increased in HH patients homozygous for
the C282Y mutation [28,40].
IRP1 activity in the mucosal cells at the villus tips and
duodenal iron absorption from the lumen show parallel
changes in iron de¢ciency [29]. Duodenal crypt cells may sense
the iron supply from the blood side and adjust the IRP activ-
ity. IRPs have been found to be more active in duodenal cells
in HH patients [30]. We hypothesize that IRP activity is
closely related to iron absorption via DCT1/DMT1, and
that it accounts for excessive iron absorption in patients
with HH.
Di¡erential splicing in the DCT1/DMT1 transporter gene
may also be important in regulating iron homeostasis. Lee et
al. demonstrated that both splice variants of DCT1/DMT1
are ubiquitously expressed at various levels and ratios in hu-
man tissues. The brain appears to express the highest ratio of
IRE to non-IRE form, and spleen, thymus and pancreas the
highest ratio of non-IRE to IRE form [7].
The present study was designed to test the role of the IRE/
IRP system in controlling DCT1/DMT1 expression. We have
investigated the ability of the DCT1/DMT1-IRE to bind to
IRP1 and IRP2, and studied the iron-dependent mechanism
of regulation of DCT1/DMT1 mRNA at the transcriptional
and post-transcriptional levels in Caco-2 (intestinal cells) and
Hep3B (liver cells) and in HeLa cells.
2. Materials and methods
2.1. Enzymatic preparation of RNA oligonucleotides for
gel-shift analysis
The RNAs used in this study were prepared enzymatically by tran-
scribing from DNA templates with T7 RNA polymerase using a pub-
lished method [20]. The oligodeoxynucleotide templates, which were
purchased commercially (Operon), each included both the bottom
strand sequence of the 17-nucleotide T7 RNA polymerase promoter
and IRE sequence to generate either of the following RNA sequences:
ferritin H-chain (Fer) IRE (5P-GGG AGA GGA UCC UGC UUC
AAC AGU GCU UGG ACG GAU CC-3P), a 38-nucleotide IRE
having a sequence derived from the human Fer IRE in its 5P-UTR,
and DCT1/DMT1 (5P-GGG AGA AGC CAU CAG AGC CAG
UGU GUU UCU AUG GUU-3P), a 36-nucleotide sequence derived
from the non-consensus IRE found in the 3P-UTR of both human and
rat DCT1/DMT1. The condition of the experiment was shown in ref.
[20].
2.2. RNA gel-shift assays
All competition reactions were prepared as follows: 33P-labelled
wild-type Fer IRE at a ¢nal concentration of 36 nM was mixed
with either a 1-, 2-, 5-, 10-, or 100-fold excess (36, 73, 182, 364, or
3640 nM) of unlabelled competitor RNA (either Fer IRE or DCT1/
DMT1-IRE) in the presence of 4.5% (v/v) glycerol, 0.1 mg/ml yeast
tRNA (non-speci¢c competitor), 3 mM DTT, 1 U/ml RNase Inhibitor
(5 Prime 3 Prime, Inc.), 40 mM KCl, 20 mM Tris^HCl (pH 7.5), and
18^30 nM IRP1 (Fig. 2A) or IRP2 (Fig. 2B). The experiment and the
calculation of the dissociation constant (Kd) for the IRE^IRP inter-
action are described in ref. [20].
2.3. Northern analysis
Endogenous DCT1/DMT1 and transfected DCT1/DMT1 in Caco2
and/or Hep3B cells were analyzed by Northern blot analysis. Poly
(A) RNA (2^3 Wg each well) was separated on a 1% formalde-
hyde/1% agarose gel and blotted onto a Nylon transfer membrane.
Digoxigenin (DIG)-labelled anti-sense transcripts were synthesized
using DIG RNA labelling kit (Roche) from a PCR fragment for
the probes. A 777-bp fragment (bases 936^1713, AF008439) was
used to detect both isoforms of human DCT1/DMT1 on resulting
Northern blots. Hybridization and washing conditions using 32P-la-
belled probes were as described previously [4]. For DIG-labelled
Northern analysis, hybridization was at 68‡C for overnight, and ¢lters
were processed according to the manufacturer’s instructions (CDP
Star, Roche).
2.4. Cell culture and transient transfections
Caco2 cells (AATCC) were cultured in Dulbecco’s modi¢ed Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum, 100 Wmol/
l non-essential amino acids, 100 U/l penicillin, 100 Wg/l streptomycin
and 1 mM sodium pyruvate. Hep3B cells were cultured in K-MEM
instead of DMEM, under the same conditions. Cells were plated and
grown for an additional 3 days before any further treatment [100 WM
hemin, 100 Wg/ml ferric ammonium citrate (FAC; Sigma), or 100 WM
desferrioxamine (Df; Sigma) for 16^18 h]. Transfections were per-
formed using FuGENE 6 (Roche) or Lipofectamine (Gibco BRL)
according to the manufacturers’ protocol. After transfection, cells
were treated as described above.
2.5. Reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA was isolated using the ‘RNAClean’ reagent (Hybaid)
and was further puri¢ed through an ‘RNeasy’ mini column (Qiagen).
To remove residual DNA from the samples, a DNase I digestion was
performed using the Qiagen RNase-free DNase set. First strand of
cDNA was obtained using the Superscript Reverse Transcription Kit
(Gibco BRL). As a negative control, a sample without reverse tran-
scriptase was included. 1/20th of the cDNA mix was used as a tem-
plate for the PCR ampli¢cation with Taq Polymerase (Perkin Elmer)
at 95‡C for 30 s, 55‡C for 90 s, 72‡C for 45 s. Samples were ampli¢ed
for 22 cycles for endogenous DCT1/DMT1 and TfR cDNAs, and 20
cycles for GAPDH. Primer sets used were: for endogenous DCT1/
DMT1, 5P-CAG ATG ACA GTG TTT CTG GA-3P and 5P-GCA
ATG GCT GAG CCA ATG AC-3P ; for TfR, 5P-CGA TAA CAG
TCA TGT GGA GA-3P and 5P-AGT AAC TGT TGC AGC CTT
AC-3P ; for GAPDH, 5P-CCA TGG AGA AGG CTG GGG-3P and
5P-CAA AGT TGT CAT GGA TGA CC-3P. The expected size for
endogenous DCT1/DMT1 is 486 bp, TfR 525 bp, and GAPDH 195
bp. For the HeLa cell experiment, another primer pair for detecting
endogenous DCT1/DMT1 was used. These primers were 5P-AAC
CCA GCC AGA GCC AGG TA-3P and 5P-CCC CCT TTG TAG
ATG TCC AC-3P. The expected size for this fragment is 349 bp.
Ethidium bromide-stained gels were scanned and quanti¢ed using
the Fuji FLA2000 FluorImager. Data for DCT1/DMT1 mRNA levels
were normalized with respect to GAPDH levels.
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2.6. Promoter-de¢cient luciferase reporter gene
In order to investigate whether the DCT1/DMT1 promoter region
is responsive to iron-dependent regulation, we have transfected the
constructs containing the human DCT1/DMT1 promoter region sub-
cloned into a promoter-de¢cient pGL3-Basic vector containing the
luciferase reporter gene (Promega). As described in ref. [31], plasmid
p(33120/+145) Luc contains a 3.2-kb EcoRI^HindIII fragment com-
prising nucleotides 33120 to +15 of the DCT1/DMT1 promoter re-
gion. Similarly, p(31849/+145) Luc, p(3714/+145) Luc, and p(3246/
+145) Luc were generated by progressive deletion from p(33120/
+145) Luc (Fig. 4A). Hep3B and/or Caco2 cells were transiently trans-
fected with luciferase constructs and L-galactosidase or Renilla lucif-
erase constructs. After transfection, cells were treated with 100 W Df
or 200 Wg/ml FAC for 20^48 h (Fig. 4B). Luciferase assays were
performed according to the manufacturer’s protocol and the data
were normalized against L-galactosidase or Renilla luciferase activity
(Promega).
2.7. Quantitative RT-PCR
We used the LightCycler PCR instrument (Roche). Selective ampli-
¢cation of the two DCT1/DMT1 splice forms was achieved by sub-
type-speci¢c primers, and the oligonucleotide sequences and the de-
tails for RT-PCR were as described elsewhere (Rolfs et al., manuscript
in review). The values for each sample were normalized to L-actin to
account for di¡erences in mRNA amount in the reactions.
2.8. Radiotracer uptake studies
Hep3B cells were cultured on 100-mm plates to about 70% con£u-
ency. Cells were transfected with mouse DCT1/DMT1-IRE or DCT1/
DMT1 non-IRE forms which was constructed in the pMT2 vector.
Two days after transfection, radiotracer uptake experiments were per-
formed by incubating cells for 20 min in 10 ml standard uptake
medium (100 mM NaCl, 10 mM HEPES and 1 mM ascorbic acid,
pH 6.2) along with 10 WM [55Fe]FeCl2 (speci¢c activity for 55FeCl3
from NEN Life Science Products, Inc. was 40.4 mCi/mg) at 37‡C.
Cells were gently washed twice with ice-cold PBS, resuspended in
0.5 ml water, and then the 0.5 ml of the suspension was added to
10 ml of scintillation £uid for scintillation counting [36].
3. Results
As shown previously, DCT1/DMT1 mRNA is upregulated
50^100-fold in the duodenum of iron-deprived rats, compared
to normal rats [4]. In all other tissues examined, we only
observed about aV1.5^3-fold upregulation in iron de¢ciency,
suggesting that the intestine is much more responsive to iron.
DCT1/DMT1 has a putative 3P-IRE which has consensus
features [11^19] of an IRE, including a six-nucleotide motif in
the stem^loop head (CAGUGN) and a single unpaired bulge
C (Fig. 1). Interestingly, it contains an unusual unpaired U in
the upper stem that could potentially distort the structure of
the IRE and interfere with IRP binding. To determine
whether the DCT1/DMT1-IRE is conserved among di¡erent
species, we PCR-ampli¢ed and sequenced the corresponding
IRE region from di¡erent species. The IRE is conserved in
rat, mouse, rabbit, and human (Fig. 1), supporting the con-
cept that the DCT1/DMT1-IRE may be involved in the reg-
ulation of this metal ion transporter via the IRE/IRP system.
Gel electrophoretic retardation assays were performed to
study whether the IRE binding proteins IRP1 and IRP2 can
interact in vitro with the DCT1/DMT1-IRE. Puri¢ed IRP1 or
IRP2 was incubated with the 33P-UTP-labelled RNA oligonu-
cleotides containing IREs derived from the Fer 5P-UTR (Fig.
2). Binding was determined in the presence or absence of
increasing amount of unlabelled IRE competitor sequence
and the mixture was analyzed by gel retardation assays (Fig.
2). The experiments show that both IRP1 and IRP2 interact
with the DCT1/DMT1-IRE, but the a⁄nities of the interac-
tions were lower than those of Fer IRE. IRP1 interacted with
the DCT1/DMT1-IRE with higher a⁄nity than IRP2. Based
on competitor analysis, the Kd values for the DCT1/DMT1-
IRE interactions were 91 pM for IRP1 and 750 pM for IRP2.
In comparison, the Kd values for Fer IRE were 30 and 29 pM,
respectively.
To further test the role of the IRE/IRP system in regulating
DCT1/DMT1, we investigated whether the DCT1/DMT1
mRNA expressed endogenously in intestinal Caco2 or liver
Hep3B cells is upregulated in response to iron depletion (Df
addition) or diminished in response to iron overload (FAC
addition). In experiments involving Caco2 cells, Df or FAC
treatment was performed 10 days after the cells were fully
con£uent and di¡erentiated. In experiments involving
Hep3B cells, Df or FAC treatment was performed after the
cells reached 80% con£uence. The expected size of the human
DCT1/DMT1-IRE and non-IRE forms are V4.1 and 3.9 kb
[7], respectively. A distinct band at V4.0 kb was observed in
Hep3B, Caco2 and HeLa cells (Fig. 3), particularly in the
iron-de¢cient state. As is shown in Fig. 5A,B, the non-IRE
form is expressed at much lower levels compared to the IRE
form, indicating that the observed band must correspond to
the IRE form. Fig. 3A,B shows substantial increases of the
4-kb band in the iron-depleted condition for both Caco2 and
Fig. 1. Conservation of the IRE stem^loop structure in the 3P-UTR of DCT1/DMT1 mRNA among di¡erent species. In all of the ¢ve species
examined, the stem^loop structure consists of a loop comprising ¢ve nucleotides, CAGUG, and an unpaired bulge C in the stem. The unpaired
U, which is indicated by a circle, is unique in the DCT1/DMT1 IREs.
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Hep3B cells, with the most dramatic responses for Caco2 cells
(V50-fold increase when comparing Df and FAC treatments).
Equal RNA loading was validated by either L-actin probing
(Fig. 3A) or ethidium bromide staining of the 18S and 28S
rRNA (Fig. 3B).
To evaluate the regulation of endogenously expressed
DCT1/DMT1 in di¡erent cell types, we performed semi-quan-
titative PCR using probes which amplify both the IRE and
non-IRE forms of DCT1/DMT1. Caco2 cells were treated
with either Df (100 WM) or hemin (100 WM) for 16 h. A
representative gel showing the alteration of the PCR products
is shown in Fig. 3C. The levels of the endogenously expressed
DCT1/DMT1 and TfR mRNAs in Caco 2 cells were V10-
fold upregulated after Df treatment, when comparing with
hemin treatment (Fig. 3C). In contrast, HeLa cells showed a
three- to ¢ve-fold change in TfR mRNA when comparing Df
with hemin treatment, but no changes were observed for
DCT1/DMT1 (Fig. 3D). This is in striking contrast to
Caco2 cells. The data indicate that the DCT1/DMT1 response
is cell type speci¢c.
We also studied whether DCT1/DMT1 may be regulated at
the transcriptional level. To address this question, we pre-
pared a series of DCT1/DMT1 promoter^luciferase reporter
constructs covering the promoter region up to nucleotide
31849 (Fig. 4A) and 33120 (data not shown). Analysis of
the constructs in transfected Hep3B, HepG2 and HeLa cells
treated with Df and FAC revealed slightly decreased promoter
activity compared to no iron treatment (Fig. 4B). In two in-
dependent experiments we observed no response to iron treat-
ment (Df versus FAC) (Fig. 4B and data not shown).
To verify which splice form of endogenous DCT1/DMT1 is
iron responsive, we performed quantitative RT-PCR using
subtype-speci¢c primers (Fig. 5A). Only the IRE form of
DCT1/DMT1 was responsive to iron both in Hep3B and
Caco2 cells, and Caco2 cells exhibited a more dramatic iron
responsiveness to iron depletion (Fig. 5A). Following Df
treatment of Caco2 cells, the expression level of the IRE
was V400-fold higher compared to the non-IRE form. The
di¡erence between Df and FAC treatment of the IRE form is
consistent with the data of the Northern analysis in Fig. 3A,B.
In contrast, the non-IRE form of DCT1/DMT1 was expressed
at much lower levels (Fig. 5B). In Hep3B control (no iron
treatment), the expression level of the IRE form was almost
100-fold higher compared to the non-IRE form (Fig. 5A).
Given the large di¡erence between the expression levels of
the IRE and non-IRE forms, the question arises as to whether
there is any functional di¡erence between the two isoforms.
Iron transport studies were performed using 55Fe (Fe2) and
Hep3B cells transfected transiently with cDNAs encoding the
DCT1/DMT1-IRE or non-IRE forms. No di¡erence in iron
Fig. 2. Gel-shift assay to demonstrate that both IRP1 and IRP2 interact with the DCT1/DMT1-IRE. A: Competition-based gel-shift assay
showing IRP1 binding to Fer IRE and DCT1/DMT1-IRE (see sequences in C). B: Competition-based gel-shift assay showing IRP2 binding to
Fer IRE and DCT1/DMT1-IRE. 33P-labelled wild-type Fer IRE (36 nM) was mixed with a 1-, 2-, 5-, 10-, or 100-fold (36, 73, 182, 364, or
3640 nM) excess of unlabelled competitor RNA (either Fer IRE or DCT1/DMT1-IRE). Experimental details are described in Section 2. C: The
DCT1/DMT1-IRE and IRP1 interaction shows a higher a⁄nity than the DCT1/DMT1-IRE and IRP2 interaction, and Kd values were 91 pM
for IRP1 and 750 pM for IRP2, based on the band-shift competition assays using consensus Fer IRE. D: The TfR-IRE used in ref. [21] is
shown. Parts C and D highlight the di¡erences in IRE stem structure: the Fer IRE stem has an internal loop shown by the circle (C, left),
whereas IREs of DCT1/DMT1 and TfR have simple bulge Cs (C, right, and D).
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uptake was observed for the two isoforms (Fig. 5C). We also
found no di¡erence in subcellular localization in these cells
(data not shown).
4. Discussion
DCT1/DMT1 mRNA and its protein are strongly (50^100-
fold) upregulated in the duodenum of iron-de¢cient animals
[4,6,27], and the level of regulation was higher in intestine
compared to other tissues such as liver, kidney, heart and
brain (see ref. [4]). Thus, iron entry in the duodenum is tightly
regulated by dietary iron availability and body iron require-
ment.
To study the mechanism of DCT1/DMT1 regulation, we
used various cultured cells expressing the transporter. We ob-
served a large (up to 50-fold) iron responsiveness to iron che-
lation with Df in endogenous DCT1/DMT1 mRNA expressed
in either intestinal Caco2 or liver Hep3B cells with more dra-
matic changes in Caco2 cells (Figs. 3A,B and 5A). There was
no signi¢cant regulation of endogenous DCT1/DMT1-IRE in
HeLa cells (Fig. 3D) or LMTK ¢broblasts, as shown earlier
[32]. The Northern analyses of tissues from normal and iron-
de¢cient rats, which show the highest responses in the duode-
num [4], indicate that the regulation of DCT1/DMT1 mRNA
expression is cell type- and organ-speci¢c. Iron responsiveness
in Caco2 cells also increased with cell con£uence (data not
shown). Taken together, these data show that DCT1/DMT1
mRNA is highly responsive to cellular iron in cell types of
intestinal or hepatic origin, whereas, in HeLa cells, it is un-
responsive, suggesting that DCT1/DMT1 mRNA regulation
depends on as yet unknown cell- or tissue-speci¢c factors and
possibly also on cell di¡erentiation, in addition to the IRE/
IRP system.
Interestingly, the predominant spliced product of DCT1/
DMT1 mRNA in Hep3B and Caco2 cells is the IRE form
(Fig. 5A), indicating that there is e⁄cient preferential splicing
of the IRE form, which has total 16 exons, compared to 17
exons for the non-IRE form [7]. Both spliced products trans-
ported iron e⁄ciently in transfected Hep3B cells (Fig. 5C).
Also, both isoforms were expressed in the plasma membrane
and later endosomal compartments (data not shown and ref.
[32]). Thus, given the current information available, the two
isoforms have similar or identical roles in vivo, but the ma-
jority of DCT1/DMT1 in Hep3B and Caco2 cells exists in the
IRE form.
Furthermore, as shown in Fig. 5B, the expression of the
non-IRE form was not altered signi¢cantly by iron treatment,
whereas the IRE form was highly responsive (Fig. 5A). The
speci¢c regulation of the IRE-splice product suggests that iron
regulation may not be due to transcriptional regulation of the
DCT1/DMT1 gene. Studies of promoter/reporter constructs
(up to V3 kb upstream of DCT1/DMT1 5P-UTR) also did
not demonstrate any iron-dependent transcription of the hu-
man DCT1/DMT1 gene (Fig. 4B). Lee et al. showed that the
human DCT1/DMT1 5P-regulatory region contains two
CCAAT boxes, but no TATA box. This regulatory region
also contains ¢ve potential metal response elements, three
potential SP1 binding sites and a single Q-interferon regulatory
element [7]. Our constructs contained all of these elements.
However, we could ¢nd neither a signi¢cant increase in pro-
moter activity in the presence of an iron chelator nor suppres-
sion by divalent metals such as iron (Fig. 4B), zinc and cad-
mium (data not shown). Given these results, it is less likely
that regulation of DCT1/DMT1 occurs at the transcriptional
level, although it cannot be completely excluded that distant
upstream enhancer elements may confer iron responsiveness.
The observed regulation of DCT1/DMT1 may involve
RNA stabilization through binding of IRP1 and/or IRP2 to
Fig. 3. Examination of DCT1/DMT1 regulation in culture by Northern analysis and RT-PCR. Response of endogenous DCT1/DMT1 mRNA
levels to 100 WM Df and 100 Wg/ml FAC in the Caco2 intestinal cell line (A) and Hep3B hepatoma cell line for 10 min and 30 min (B). L-Ac-
tin and ethidium bromide staining of rRNA were included as loading controls. Semi-quantitative PCR for the DCT1/DMT1-IRE form and
TfR RNAs in Caco2 (C) and HeLa cells (D) treated with hemin or Df. GAPDH was measured as a control. In panel C, lanes 2 and 3 and
lanes 4 and 5 represent duplicate experiments.
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the putative IRE in DCT1/DMT1. We show that DCT1/
DMT1-IRE can bind both IRP1 and IRP2, but the a⁄nity
for IRP1 was considerably higher (Fig. 2), and the low a⁄nity
of the DCT1/DMT1 IRE for IRP2 may fall to within a range
that is insu⁄cient to mediate regulation [20]. The IRP1 a⁄n-
ity (Kd of 91 þ 4 pM) is somewhat lower than that of Fer IRE
(whose Kd is V30 þ 20 pM). The latter is similar to the IRP1
Kd values for TfR or eALAS [21,35]. Ke et al. also showed
that the Fer IRE is recognized equally by both IRP1 and
IRP2. However, if the internal loop was mutated to form a
simple bulge C (analogous to that in Fig. 2D), decreased IRP2
binding a⁄nity was observed [21]. The simple bulge C struc-
ture is a common feature of the IREs of DCT1/DMT1 (Fig.
2C, right), TfR (Fig. 2D), eALAS [21] and m-aconitase IREs
[21], all of which exhibit low IRP2 a⁄nity, whereas the pro-
posed Fer IRE internal loop/bulge structure (Fig. 2C) appears
to be di¡erent from the single bulge C described above [39,21].
This suggests that the regulation of DCT1/DMT1, TfR, eA-
LAS and m-aconitase are more dependent on IRP1 than
IRP2. IRP1/IRP2 ratios vary signi¢cantly in di¡erent cell
types. IRP1 levels are higher in liver, kidney and intestine
[34], suggesting that the cell type- and organ-speci¢c expres-
sion of DCT1/DMT1 may correlate with the organ-speci¢c
distribution of IRP1 and IRP2 [37,38]. Future studies, includ-
ing the analysis of the phenotype caused by targeted disrup-
tion of the IRP1 gene, will be required to determine the exact
role of IRP1 in regulating DCT1/DMT1-mediated iron trans-
port.
As shown in Figs. 1 and 2C, the hairpin loop structure is
conserved in all IREs reported to date. The only remarkable
di¡erences in these IREs are the stem structure, in particular
the internal loop/bulge in Fer, the C bulge in the other IREs
and the additional U bulge in DCT1/DMT1. These variations
in structure may determine IRP2 binding [21,35] and thus the
Fig. 5. A,B: Evaluation of the iron responsiveness of the IRE and
non-IRE forms of DCT1 by quantitative PCR and (C) 55Fe uptake
by the IRE- and non-IRE forms of DCT1/DMT1 in Hep3G cells.
Quantitative RT-PCR for DCT1/DMT1-IRE (A) and DCT1/DMT1
non-IRE (B) with mRNA from Hep3B and Caco2 cells treated with
Df, FAC or no treatment. The Y axis indicates DCT1/DMT1 ex-
pression levels normalized by L-actin. The values for each sample
were normalized to L-actin to account for di¡erences in mRNA
amount in the reactions. C: 55Fe uptake in Hep3G cells transfected
with either of the two isoforms of DCT1/DMT1.
Fig. 4. Examination of the transcriptional regulation of expression
of DCT1. A: Luciferase constructs of the human DCT1/DMT1
gene promoter placed upstream of the luciferase reporter gene. The
pGL3-basic vector (Promega) was used in these experiments. DCT1/
DMT1 5P-promoter deletions were made as described in Section 2,
and ref. [31]. B: Hep3B cells were transiently transfected with lucif-
erase constructs and L-galactosidase or Renilla luciferase constructs.
After transfection, cells were treated with 100 WM Df or 100^200
Wg/ml FAC for 20^48 h. Each bar indicates relative luciferase activ-
ity in Hep3B cells transfected with luciferase reporter constructs
shown in A.
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di¡erential binding ratio of IRP1 and IRP2. Because IRP1
binding a⁄nity is lower in DCT1/DMT1-IRE compared to
Fer IRE shown in Fig. 2C, the additional U bulge in
DCT1/DMT1 may potentially further decrease IRP2 binding
a⁄nity.
Experiments with transiently transfected DCT1/DMT1
c-myc constructs containing the 3P-UTR IRE did not exhibit
signi¢cant iron-dependent mRNA regulation in either Caco2
or Hep3B cells (data not shown). This apparent lack of re-
sponsiveness may have been due to overexpression of DCT1/
DMT1-IRE. This may have compromised iron responsiveness
because excessive IRE-mRNA can saturate the IRP system,
including IRPs and putative nucleases or cell di¡erentiation-
speci¢c factors. Because Casey et al. used in their TfR-IRE
studies constructs with the TfR promoter itself, their experi-
ments avoided overexpression and, therefore, mimicked the in
vivo situation more closely [10]. Alternatively, lack of respon-
siveness may have been due to missing 5P- and/or 3P-untrans-
lated sequences.
In summary, our results demonstrate that endogenous
DCT1/DMT1 expression in Caco2 and Hep3B is highly re-
sponsive to iron treatment, consistent with the observed re-
sponse in rat and human duodenum [4,28]. Responsiveness
depends on cell type and cell con£uence, suggesting that
cell- and di¡erentiation-speci¢c factors may be involved in
regulation. We show that IRP1 binds with high a⁄nity to
the DCT1/DMT1-IRE, whereas IRP2 binds with much lower
a⁄nity. Our studies show that only the DCT1/DMT1 splice
form containing the IRE is responsive to iron, both in cul-
tured cells (Fig. 5A) and in human intestine (Rolfs et al.,
manuscript in review). We propose that DCT1/DMT1
mRNA is regulated through stabilization by the IRE/IRP
system, in analogy to TfR mRNA. However, the exact mech-
anisms which confer cell type- and/or di¡erentiation-speci¢c
regulation remain yet to be elucidated.
In vivo, DCT1/DMT1 mRNA stabilization is likely the
predominant mechanism for iron-dependent regulation, allow-
ing massive accumulation of the IRE splice product during
iron starvation. The transfer of iron from the intestinal lumen
into the blood requires not only DCT1/DMT1 in the brush
border membrane but also an iron exit mechanism at the
basolateral side of enterocytes. The molecular identity of
this mechanism has recently been unraveled. It consists of
an iron transporter, called IREG1/Ferroportin1/MTP1 [17^
19], and a multi-copper oxidase, called hephaestin [33]. Inter-
estingly, IREG1/Ferroportin1/MTP1 also has an IRE located
in the 5P-UTR [17^19], in analogy to ferritin where the 5P-IRE
regulates translation in an iron-dependent manner. Abboud
and Haile demonstrated that MTP1 IRE was functional
[19]. We propose that the IREs in DCT1/DMT1 and
IREG1/Ferroportin1/MTP1 play a crucial role in maintaining
continuous transepithelial iron transport in the intestine. If
serum iron levels are low, DCT1/DMT1 will be expressed
maximally in the brush border membrane of enterocytes.
We hypothesize that IREG1/Ferroportin1/MTP1 mRNA is
on translational or transcriptional arrest until DCT1/DMT1
delivers iron into enterocytes to trigger its expression and
localization in the basolateral membrane and to facilitate
transfer of iron into the blood.
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